Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Devine

Showing results (541-550 of 577) with videos related to

Pageof 58
Sort By:
Blood|September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantationV Ratanatharathorn, R A Nash, D Przepiorka, et al.
JAMA Oncology|May 2, 2024
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaLaura W Dillon, Gege Gui, Niveditha Ravindra, et al.
Blood Advances|June 9, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment TrialAsad Bashey, Brent R Logan, LaQuisa C Hill, et al.
Bone Marrow Transplantation|November 6, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Molecular Genetics and Metabolism|July 30, 2018
Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria CentreL R Ranganath, M Khedr, A M Milan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 3, 2009
Outcome of transplantation for myelofibrosisKaren K Ballen, Smriti Shrestha, Kathleen A Sobocinski, et al.
Data in Brief|September 29, 2018
Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinoneR Griffin, E E Psarelli, T F Cox, et al.
Bone Marrow Transplantation|October 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Transplantation and Cellular Therapy|March 16, 2023
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchJeffery J Auletta, Jianqun Kou, Min Chen, et al.
Transplantation and Cellular Therapy|August 30, 2021
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th YearHelen E Heslop, Edward A Stadtmauer, John E Levine, et al.
Pageof 58

Showing results (541-550 of 577) with videos related to

Sort By:
Pageof 58
Blood|September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantationV Ratanatharathorn, R A Nash, D Przepiorka, et al.
JAMA Oncology|May 2, 2024
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaLaura W Dillon, Gege Gui, Niveditha Ravindra, et al.
Blood Advances|June 9, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment TrialAsad Bashey, Brent R Logan, LaQuisa C Hill, et al.
Bone Marrow Transplantation|November 6, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Molecular Genetics and Metabolism|July 30, 2018
Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria CentreL R Ranganath, M Khedr, A M Milan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 3, 2009
Outcome of transplantation for myelofibrosisKaren K Ballen, Smriti Shrestha, Kathleen A Sobocinski, et al.
Data in Brief|September 29, 2018
Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinoneR Griffin, E E Psarelli, T F Cox, et al.
Bone Marrow Transplantation|October 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Transplantation and Cellular Therapy|March 16, 2023
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchJeffery J Auletta, Jianqun Kou, Min Chen, et al.
Transplantation and Cellular Therapy|August 30, 2021
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th YearHelen E Heslop, Edward A Stadtmauer, John E Levine, et al.
Pageof 58